Smith & Nephew (SN.) Stock Overview
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
SN. Community Fair Values
Create NarrativeSee what 62 others think this stock is worth. Follow their fair value or set your own to get alerts.
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£12.63 |
| 52 Week High | UK£14.42 |
| 52 Week Low | UK£9.61 |
| Beta | 0.74 |
| 1 Month Change | 1.20% |
| 3 Month Change | 3.99% |
| 1 Year Change | 27.16% |
| 3 Year Change | 5.51% |
| 5 Year Change | -10.68% |
| Change since IPO | 6,272.09% |
Recent News & Updates
Recent updates
Do Smith & Nephew's (LON:SN.) Earnings Warrant Your Attention?
Jan 24
Earnings Tell The Story For Smith & Nephew plc (LON:SN.)
Dec 23Investors Will Want Smith & Nephew's (LON:SN.) Growth In ROCE To Persist
Dec 10Is Smith & Nephew plc (LON:SN.) Trading At A 21% Discount?
Nov 13Do Smith & Nephew's (LON:SN.) Earnings Warrant Your Attention?
Oct 14Is Smith & Nephew (LON:SN.) A Risky Investment?
Sep 30We Like These Underlying Return On Capital Trends At Smith & Nephew (LON:SN.)
Aug 28We Think Smith & Nephew's (LON:SN.) Robust Earnings Are Conservative
Aug 12Smith & Nephew plc Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next
Aug 08Estimating The Fair Value Of Smith & Nephew plc (LON:SN.)
Aug 04Smith & Nephew plc's (LON:SN.) Popularity With Investors Is Clear
Jun 27Smith & Nephew (LON:SN.) Is Finding It Tricky To Allocate Its Capital
May 24We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt
May 09Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 21%?
Apr 24
Restructuring Will Improve Operating Efficiency By 2025
Strategic restructuring and innovative platforms like CORI and REGENETEN are enhancing revenue growth and operational efficiency, impacting margins positively as macroeconomic conditions stabilize.Shareholder Returns
| SN. | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 5.9% | 7.2% | 2.9% |
| 1Y | 27.2% | 13.0% | 28.2% |
Return vs Industry: SN. exceeded the UK Medical Equipment industry which returned 10.8% over the past year.
Return vs Market: SN. underperformed the UK Market which returned 29.5% over the past year.
Price Volatility
| SN. volatility | |
|---|---|
| SN. Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in GB Market | 12.0% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: SN. has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: SN.'s weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 16,988 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
| SN. fundamental statistics | |
|---|---|
| Market cap | UK£10.79b |
| Earnings (TTM) | UK£460.82m |
| Revenue (TTM) | UK£4.54b |
Is SN. overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SN. income statement (TTM) | |
|---|---|
| Revenue | US$6.16b |
| Cost of Revenue | US$1.96b |
| Gross Profit | US$4.21b |
| Other Expenses | US$3.58b |
| Earnings | US$625.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.73 |
| Gross Margin | 68.25% |
| Net Profit Margin | 10.14% |
| Debt/Equity Ratio | 58.8% |
How did SN. perform over the long term?
See historical performance and comparisonDividends
Does SN. pay a reliable dividends?
See SN. dividend history and benchmarks| Smith & Nephew dividend dates | |
|---|---|
| Ex Dividend Date | Mar 26 2026 |
| Dividend Pay Date | May 27 2026 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 42 days |
Does SN. pay a reliable dividends?
See SN. dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/14 06:14 |
| End of Day Share Price | 2026/04/14 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Smith & Nephew plc is covered by 34 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sally Taylor | Barclays |
| Hassan Al-Wakeel | Barclays |
| Samuel England | Berenberg |